ResearcherNo recent work listed
Nausika Betriu
Matched on ORCID iD 0000-0001-5167-1371; OpenAlex author ID A5068565251.
Their work
- Papers
- 3 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 1
2021: 2 papers · 2022: 1 paper
Papers 3
- Increased Stiffness Downregulates Focal Adhesion Kinase Expression in Pancreatic Cancer Cells Cultured in 3D Self-Assembling Peptide Scaffolds. First author DOI 10.3390/biomedicines10081835↗
- Syndecans and Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/biom11030349↗
- Erlotinib Promotes Ligand-Induced EGFR Degradation in 3D but Not 2D Cultures of Pancreatic Ductal Adenocarcinoma Cells. First author DOI 10.3390/cancers13184504↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Carlos E. Semino · 3 shared papers, 2021–2022
- Paper Increased Stiffness Downregulates Focal Adhesion Kinase Expression in Pancreatic Cancer Cells Cultured in 3D Self-Assem… DOI 10.3390/biomedicines10081835↗
- Paper Erlotinib Promotes Ligand-Induced EGFR Degradation in 3D but Not 2D Cultures of Pancreatic Ductal Adenocarcinoma Cells. DOI 10.3390/cancers13184504↗
- Paper Syndecans and Pancreatic Ductal Adenocarcinoma. DOI 10.3390/biom11030349↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.